The mRNA vaccine success vs melanoma in a Phase definitive 3 randomized trial today is on top of signs of success for personalized mRNA neoantigen vaccines vs pancreatic cancer, triple negative breast cancer, and non-small cell lung cancer https://t.co/cv4iXW11mw #mRNAvaccine #CancerResearch #Immunotherapy #Nospecificcountrycodesarementionedinthetweet.